Loading...
Drägerwerk AG & Co. KGaA
DWRKF•PNK
Healthcare
Medical - Devices
$543.70
$543.70(1.1971920924108106e+42%)

Financial performance has remained strong, with revenue growing from $735.82M in Q1 2024 to $774.57M in Q3 2024. Gross profit continued to perform well, with margins at 44% in the latest quarter. Operating income reached $24.008M in Q3 2024, holding a steady 3% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $24.008M. Net income dropped to $14.66M, keeping EPS at $0.77. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan